One of the most popular diets and lifestyle programmes for people with MS is coming to Brighton on 22 October 2017. Overcoming Multiple Sclerosis will be hosting a one-day conference event at AMEX...
Our news web pages include ground-breaking multiple sclerosis news and research from around the world.
These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.
Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content.
We’re here to support you, whether you are awaiting a diagnosis of multiple sclerosis or have been living with the condition for years.
One of the most popular diets and lifestyle programmes for people with MS is coming to Brighton on 22 October 2017. Overcoming Multiple Sclerosis will be hosting a one-day conference event at AMEX...
A study has revealed how remotely supervised transcranial direct current stimulation (RS-tDCS) can help with the treatment of fatigue in multiple sclerosis (MS) patients.
Fatigue is a...
UK patients are set to take part in a $10 million international clinical trial to discover whether giving MS patients the strongest available medicines from the beginning of their illness is more...
A team of researchers have identified Opioid Growth Factor (OGF) as a novel biomarker for the onset and progression of multiple sclerosis (MS).
The study was published in Experimental...
Researchers who have studied whether concussion in childhood or adolescence is associated with subsequent multiple sclerosis (MS) have found that a head trauma can raise the risk of developing the...
Researchers at the University of Florida Health have found a way to inhibit or reverse multiple sclerosis (MS) using a novel gene therapy technique that stops the condition’s immune response in...
Scientists at Yale University have uncovered two closely related cytokines – molecules involved in cell communication and movement – that may explain why some people develop progressive multiple...
Two new studies from the U.S and Germany have added to growing evidence that gut bacteria may play a role in the brain inflammation caused by Multiple Sclerosis.
The first study, titled...
Bexarotene, a drug that could help the brain regrow myelin in people with MS, has started its phase II clinical trial.
Researchers at Cambridge Centre for Myelin Repair and Edinburgh Centre...
NHS England has launched a series of practical guides to help disabled patients access GP online services.
Aimed at supporting people with sight loss, hearing loss, autism or learning...